Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

Market Cap	2.82B
Revenue (ttm)	371.03M
Net Income (ttm)	-19.11M
Shares Out	93.57M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.33%)
Ex-Dividend Date	May 29, 2025

Volume	5,505,980
Average Volume	6,694,778
Open	29.24
Previous Close	28.86
Day's Range	28.93 - 30.84
52-Week Range	17.46 - 46.59
Beta	0.49
RSI	58.41
Earnings Date	Apr 29, 2026

About SHA:688393

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridizatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 779
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688393

Financial Performance

In 2024, SHA:688393's revenue was 470.79 million, a decrease of -5.33% compared to the previous year's 497.29 million. Earnings were 21.29 million, a decrease of -46.85%.